Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Kirkham

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|December 1, 1995
Mathematical considerations of competitive polymerase chain reactionA R Connolly, L G Cleland, B W Kirkham
The Journal of Rheumatology|April 1, 1995
Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in sclerodermaM R Patrick, B W Kirkham, M Graham, et al.
Neuropeptides|October 7, 2000
Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the ratJ S Walker, C Scott, K A Bush, et al.
Arthritis and Rheumatism|October 11, 2001
Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndromeP A Bird, S P Oakley, R Shnier, et al.
Scandinavian Journal of Rheumatology|October 9, 2002
Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI) on cytokine expression in adjuvant arthritisK A Bush, J S Walker, J Frazier, et al.
Clinical and Experimental Immunology|April 12, 2001
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early diseaseK A Bush, J S Walker, C S Lee, et al.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1990
Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trialM M Corkill, B W Kirkham, I C Chikanza, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|December 1, 1995
Mathematical considerations of competitive polymerase chain reactionA R Connolly, L G Cleland, B W Kirkham
The Journal of Rheumatology|April 1, 1995
Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in sclerodermaM R Patrick, B W Kirkham, M Graham, et al.
Neuropeptides|October 7, 2000
Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the ratJ S Walker, C Scott, K A Bush, et al.
Arthritis and Rheumatism|October 11, 2001
Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndromeP A Bird, S P Oakley, R Shnier, et al.
Scandinavian Journal of Rheumatology|October 9, 2002
Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI) on cytokine expression in adjuvant arthritisK A Bush, J S Walker, J Frazier, et al.
Clinical and Experimental Immunology|April 12, 2001
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early diseaseK A Bush, J S Walker, C S Lee, et al.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
British Journal of Rheumatology|August 1, 1990
Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a 24-week randomized controlled trialM M Corkill, B W Kirkham, I C Chikanza, et al.
Pageof 4